Antimicrobial resistance of Neisseria gonorrhoeae in Latin American countries: a systematic review
Journal of Antimicrobial Chemotherapy · 01.06.2023 · 78 (6) · 1322-1336
DOI: 10.1093/jac/dkad071 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 18.05.2023. Verfasst von María Macarena Sandoval und 7 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Efectividad Clínica y Sanitaria (IECS-CONICET), Buenos Aires, Argentina. Hauptthemen laut MEDLINE: Gonorrhea, Anti-Infective Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: GlaxoSmithKline Biologicals SA.
Abstract (Originalsprache)
Background
Detailed information is needed on the dynamic pattern of antimicrobial resistance (AMR) in Neisseria gonorrhoeae in Latin America and the Caribbean (LAC).
Objectives
To conduct a systematic review of AMR in N. gonorrhoeae in LAC.
Methods
Electronic searches without language restrictions were conducted in PubMed, Embase, Cochrane Library, EconLIT, Cumulative Index of Nursing and Allied Health Literature, Centre for Reviews and Dissemination, and Latin American and Caribbean Literature in Health Sciences. Studies were eligible if published between 1 January 2011 and 13 February 2021, conducted in any LAC country (regardless of age, sex and population) and measured frequency and/or patterns of AMR to any antimicrobial in N. gonorrhoeae. The WHO Global Gonococcal Antimicrobial Surveillance Programme (WHO-GASP) for LAC countries and Latin American AMR Surveillance Network databases were searched. AMR study quality was evaluated according to WHO recommendations.
Results
AMR data for 38, 417 isolates collected in 1990–2018 were included from 31 publications, reporting data from Argentina, Brazil, Colombia, Peru, Uruguay, Venezuela and WHO-GASP. Resistance to extended-spectrum cephalosporins was infrequent (0.09%–8.5%). Resistance to azithromycin was up to 32% in the published studies and up to 61% in WHO-GASP. Resistance to penicillin, tetracycline and ciprofloxacin was high (17.6%–98%, 20.7%–90% and 5.9%–89%, respectively). Resistance to gentamicin was not reported, and resistance to spectinomycin was reported in one study.
Conclusions
This review provides data on resistance to azithromycin, potentially important given its use as first-line empirical treatment, and indicates the need for improved surveillance of gonococcal AMR in LAC.
Trial registration
Registered in PROSPERO, CRD42021253342.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Instituto de Efectividad Clínica y Sanitaria (IECS-CONICET), Buenos Aires, Argentina.
- Centro de Investigaciones Epidemiológicas y Salud Pública (CIESP-IECS), CONICET, Buenos Aires, Argentina.
- GSK, Buenos Aires, Argentina.
- GSK, Wavre, Belgium.
ORCID-Profile: Ariel Bardach
Förderung
- GlaxoSmithKline Biologicals SA
Zitieren
APA
Sandoval, M. M., Bardach, A., Rojas-Roque, C., Alconada, T., Gomez, J. A., Pinto, T., Palermo, C., & Ciapponi, A. (2023). Antimicrobial resistance of Neisseria gonorrhoeae in Latin American countries: a systematic review. Journal of Antimicrobial Chemotherapy, 78(6), 1322-1336. https://doi.org/10.1093/jac/dkad071
Vancouver
Sandoval MM, Bardach A, Rojas-Roque C, Alconada T, Gomez JA, Pinto T, et al. Antimicrobial resistance of Neisseria gonorrhoeae in Latin American countries: a systematic review. Journal of Antimicrobial Chemotherapy. 2023;78(6):1322-1336. doi:10.1093/jac/dkad071
BibTeX
@article{Sandoval2023,
author = {Sandoval, María Macarena and Bardach, Ariel and Rojas-Roque, Carlos and Alconada, Tomás and Gomez, Jorge A and Pinto, Thatiana and Palermo, Carolina and Ciapponi, Agustin},
title = {Antimicrobial resistance of Neisseria gonorrhoeae in Latin American countries: a systematic review},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2023},
volume = {78},
number = {6},
pages = {1322--1336},
doi = {10.1093/jac/dkad071}
}
EUVIMED